{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:30:32Z","timestamp":1786516232931,"version":"build-2736575974"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent enteropathic diarrhea is a quality-of-life-limiting complication after one-anastomosis gastric bypass (OAGB). Patients with type 2 diabetes mellitus (T2DM) may be especially vulnerable owing to subclinical diabetic enteropathy and reduced pancreatic exocrine reserve, but no validated preoperative tool identifies them. We aimed to identify and internally validate routine preoperative predictors of persistent enteropathic diarrhea 12 months after OAGB in a T2DM cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center prospective cohort of 87 consecutive patients with T2DM who underwent primary OAGB (January 2020 \u2013 December 2024) and completed\u2009\u2265\u200912 months of follow-up, the primary outcome was persistent enteropathic diarrhea, defined as loose or watery stools at all three of the 3-, 6-, and 12-month visits. Preoperative HbA1c, serum albumin, C-reactive protein, coprogram findings, T2DM duration, and antidiabetic regimen were assessed by univariate and multivariable logistic regression, with internal validation by bootstrap resampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Persistent enteropathic diarrhea occurred in 26 of 87 patients (29.9%, 95% CI 20.5\u201340.6%). Three preoperative variables were independently associated with the outcome: HbA1c (OR 2.28 per 1%, 95% CI 1.53\u20133.73), steatorrhea on coprogram (aOR 4.36, 95% CI 1.21\u201316.82), and T2DM duration\u2009\u2265\u200910 years (OR 3.90, 95% CI 1.02\u201316.16). The multivariable model showed good calibration and discrimination, with an area under the receiver operating characteristic curve (AUC) of 0.863, but HbA1c alone provided comparable performance (AUC 0.827) with no significant additional gain from the full model. At a Youden-optimal HbA1c threshold of\u2009\u2265\u20098.25%, the negative predictive value reached 95.2%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In T2DM patients undergoing OAGB, preoperative HbA1c is a robust, clinically accessible single-variable predictor of persistent enteropathic diarrhea at 12 months; coprogram steatorrhea and long-standing diabetes add complementary pathophysiological context. These routine metrics can inform preoperative counseling and risk-adapted postoperative surveillance, and warrant prospective external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1901971","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:54:59Z","timestamp":1786514099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative predictors of persistent enteropathic diarrhea after one-anastomosis gastric bypass in patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Ilkhom B.","family":"Khayitov","sequence":"first","affiliation":[{"name":"Department of Surgical Diseases in Family Medicine, Tashkent State Medical University","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhmadjon B.","family":"Babajonov","sequence":"additional","affiliation":[{"name":"Department of Surgical Diseases in Family Medicine, Tashkent State Medical University","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidislomxon S.","family":"Sayidburxonov","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Central Asian Medical University","place":["Fergana, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th Edition of the IDF diabetes atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes \u2013 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s11695-020-04519-y","article-title":"IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study","volume":"30","author":"Ramos","year":"2020","journal-title":"Obes Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12893-025-03215-x","article-title":"One anastomosis gastric bypass (OAGB): a scoping review","volume":"25","author":"Ort\u00edz-G\u00f3mez","year":"2025","journal-title":"BMC Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1007\/s11695-023-06556-9","article-title":"One anastomosis gastric bypass (OAGB) with a 150-cm biliopancreatic limb (BPL) versus a 200-cm BPL, a systematic review and meta-analysis","volume":"33","author":"Salman","year":"2023","journal-title":"Obes Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/dmrr.70033","article-title":"Comparison of benefits and risks of metabolic surgery for long-term (5 years) weight loss and diabetes remission in overweight\/obese patients with type 2 diabetes: a systematic review and network meta-analysis of randomized trials","volume":"41","author":"Zang","year":"2025","journal-title":"Diabetes Metab Res Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12902-022-01171-8","article-title":"Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study","volume":"22","author":"Moradi","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.clnu.2019.03.008","article-title":"Nutritional status following one anastomosis gastric bypass","volume":"39","author":"Kessler","year":"2020","journal-title":"Clin Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/nu14020304","article-title":"The effects of one anastomosis gastric bypass surgery on the gastrointestinal tract","volume":"14","author":"Kaniel","year":"2022","journal-title":"Nutrients"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.3748\/wjg.v23.i26.4689","article-title":"Diarrhea after bariatric procedures: diagnosis and therapy","volume":"23","author":"Borb\u00e9ly","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.endinu.2019.09.013","article-title":"Review of the management of diarrhea syndrome after a bariatric surgery","volume":"67","author":"Brunet","year":"2020","journal-title":"Endocrinol Diabetes Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12893-024-02438-8","article-title":"Prevention of malnutrition after one anastomosis gastric bypass: value of the common channel limb length","volume":"24","author":"Mostafapour","year":"2024","journal-title":"BMC Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13300-018-0454-9","article-title":"Diabetic gastroparesis: principles and current trends in management","volume":"9","author":"Krishnasamy","year":"2018","journal-title":"Diabetes Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1007\/s11695-021-05641-1","article-title":"Hypoalbuminemia predicts serious complications following elective bariatric surgery","volume":"31","author":"McLean","year":"2021","journal-title":"Obes Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1007\/s11695-025-08348-9","article-title":"Unveiling predictors of hypoalbuminemia following one anastomosis gastric bypass (OAGB): a retrospective analysis","volume":"35","author":"Ali","year":"2025","journal-title":"Obes Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Poor nutritional status and inflammation: serum albumin: relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1590\/S0102-6720201500S100005","article-title":"C-reactive protein in diabetic patients before gastric bypass as a possible marker for postoperative complication","volume":"28","author":"Lins","year":"2015","journal-title":"Arq Bras Cir Dig"},{"key":"B20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1901971\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:54:59Z","timestamp":1786514099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1901971\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":21,"alternative-id":["10.3389\/fsurg.2026.1901971"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1901971","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1901971"}}